High Potency APIs Market Analysis Report 2022: Therapeutic Application, Type of Synthesis, Type of Manufacturers – Global Forecast to 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “High Potency APIs Market Analysis by Therapeutic Application, by Type of Synthesis, By Type of Manufacturers, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including therapeutic application, type of synthesis, type of manufacturer, and type from 2022-2029.

Increasing demand for antibody-drug conjugates, precision medicine is becoming more popular, improvements in high potency API manufacturing technology and leading pharmaceutical corporations are putting a greater emphasis on high potency APIs, and oncology medications are becoming more popular are some of the key drivers of the market.

However, the increasing number of product-related uncertainties, and growing demand for major investments in employee safety.

Regional Markets

In 2021, North America had the largest market share because of the rising oncology sector, prevalence and incidence of chronic illnesses, and lifestyle diseases driving the market segment in North America. Following North America, Europe, and Asia-Pacific is the world’s fastest expanding market.

Growth in the elderly population, high incidence of chronic and lifestyle disorders, rise in disposable income, the prevalence of lifestyle- and age-related diseases, government attempts to reform healthcare and encourage the usage of generics, and rising market for merchant manufacturers in Asia due to low labor and production costs are driving the market in Asia.

Company Profiles

• Sanofi (France)
• Eli Lilly and Company (US)
• Bayer AG (Germany)
• Novartis International AG (Switzerland)
• Pfizer Inc. (US)
• Merck & Co. Inc. (US)
• Bristol-Myers Squibb Company (US)
• AbbVie (US)
• Viatris Inc. (US)
• F. Hoffmann-La Roche (Switzerland)
• Boehringer Ingelheim International GmbH. (Germany)
• Teva Pharmaceutical Industries Ltd. (Israel).

Segmentation: High Potency APIs Market Analysis Report 2021-2029

Therapeutic Application (Revenue, USD Million)

• Glaucoma
• Oncology
• Hormonal Imbalance
• Other therapeutic applications

Type of Synthesis (Revenue, USD Million)

• Biotech API Market
• Synthetic API Market

Type of Manufacturers (Revenue, USD Million)

• Merchant API Market
• Captive API Market

Type (Revenue, USD Million)

• Generic API Market
• Innovative API Market

By Region (Revenue, USD Million)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• GCC
• Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/a1dkvu

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900